Drug Repurposing Against SARS-CoV2
eBook - ePub

Drug Repurposing Against SARS-CoV2

  1. English
  2. ePUB (mobile friendly)
  3. Available on iOS & Android
eBook - ePub

Drug Repurposing Against SARS-CoV2

About this book

Drug repurposing is a cost-effective method of discovering new treatments for diseases than traditional drug development methods. It involves virtual screening of chemical candidates with the aid of computational methods like molecular docking. Drug Repurposing against SARS-CoV2 focuses on current trends in drug repurposing against the novel coronavirus strains. The book aims to give readers an overview of drug repurposing against COVID-19 and various techniques involved in the process. The book consolidates available information on the pathophysiology, drug targets, and drug repurposing against COVID-19 into a single, convenient resource. Key features • An up-to-date compilation of the evidence that supports the drug repurposing for COVID-19. • How to use repurposing of available drugs for disease therapy. • Provides an improved understanding of pathophysiology and SARS-CoV2 viral entry pathways. • Provides references for further reading

Frequently asked questions

Yes, you can cancel anytime from the Subscription tab in your account settings on the Perlego website. Your subscription will stay active until the end of your current billing period. Learn how to cancel your subscription.
No, books cannot be downloaded as external files, such as PDFs, for use outside of Perlego. However, you can download books within the Perlego app for offline reading on mobile or tablet. Learn more here.
Perlego offers two plans: Essential and Complete
  • Essential is ideal for learners and professionals who enjoy exploring a wide range of subjects. Access the Essential Library with 800,000+ trusted titles and best-sellers across business, personal growth, and the humanities. Includes unlimited reading time and Standard Read Aloud voice.
  • Complete: Perfect for advanced learners and researchers needing full, unrestricted access. Unlock 1.4M+ books across hundreds of subjects, including academic and specialized titles. The Complete Plan also includes advanced features like Premium Read Aloud and Research Assistant.
Both plans are available with monthly, semester, or annual billing cycles.
We are an online textbook subscription service, where you can get access to an entire online library for less than the price of a single book per month. With over 1 million books across 1000+ topics, we’ve got you covered! Learn more here.
Look out for the read-aloud symbol on your next book to see if you can listen to it. The read-aloud tool reads text aloud for you, highlighting the text as it is being read. You can pause it, speed it up and slow it down. Learn more here.
Yes! You can use the Perlego app on both iOS or Android devices to read anytime, anywhere — even offline. Perfect for commutes or when you’re on the go.
Please note we cannot support devices running on iOS 13 and Android 7 or earlier. Learn more about using the app.
Yes, you can access Drug Repurposing Against SARS-CoV2 by Tabish Qidwai in PDF and/or ePUB format, as well as other popular books in Medicina & Malattie infettive. We have over one million books available in our catalogue for you to explore.

Information

Table of contents

  1. Welcome
  2. Table of Content
  3. Title
  4. BENTHAM SCIENCE PUBLISHERS LTD.
  5. FOREWORD
  6. PREFACE
  7. List of Contributors
  8. Repurposing Drugs: A New Paradigm and Hopes for Life-threatening Diseases
  9. Exploration of Repurposed and Adjuvant Drugs in COVID-19 Patients, as well as Challenges and Ethical Issues Related to Drug Repurposing
  10. Repurposed Drugs Against SARS-CoV-2 Replication in COVID-19
  11. Targeting the Viral Entry Pathways through Repurposed Drugs in Sars-Cov-2 Infection
  12. Repurposed Drugs/Potential Pharmacological Agents Targeting Cytokine Release and Induction of Coagulation in COVID-19
  13. High Throughput Screening (HTS) Methods for Screening of Known Drugs for COVID-19
  14. Drug Repurposing for COVID-19 using Computational Methods